4//SEC Filing
Humphrey Jeffrey 4
Accession 0000899243-22-018819
CIK 0001690585other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:23 PM ET
Size
5.5 KB
Accession
0000899243-22-018819
Insider Transaction Report
Form 4
Humphrey Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-17+50,000→ 50,000 totalExercise: $1.18Exp: 2032-05-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001816944
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:23 PM ET
- Size
- 5.5 KB